Home > Insider Trading > Filing (0001373604-24-000056)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1557746	Aclaris Therapeutics Inc.	ACRS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1373603	Michael Braden Leonard	65 E Cedar - Suite 2 Zionsville IN 46077		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-07-30	173,730	$1.30	13,776,421	No	4	P	Indirect	Holding of BML Investment Partners, L.P.
Common Stock	Acquisiton	2024-07-31	100,000	$1.33	13,876,421	No	4	P	Indirect	Holding of BML Investment Partners, L.P

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Holding of BML Investment Partners, L.P.
No	4	P	Indirect	Holding of BML Investment Partners, L.P

Footnotes

BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
Represents shares purchased in multiple transactions resulting in a weighted average purchase price of $1.303 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
Represents shares purchased in multiple transactions resulting in a weighted average purchase price of $1.3264 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.